SCHEMBL17631706

SCHEMBL17631706

N#CN(C(=O)C1CCNC1)c1ncc(CN2CCOCC2)s1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.36
▸ KDM1A O60341 1/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ LMNA P02545 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ OGA O60502 4/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ PLAT P00750 1/20 0.34
▸ UCHL1 P09936 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17631911 0.86 UCHL1 (0.45) KDM1APLATUCHL1
SCHEMBL17632075 0.81 POLB (0.35) KMT2AMEN1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL17632104 0.81 SLC6A2 (0.33) —
SCHEMBL17631923 0.78 UCHL1 (0.50) KMT2AMEN1ALDH1A1MAPK1LMNA
SCHEMBL17631689 0.77 SMN1; SMN2 (0.35) KDM1AKMT2AMEN1SMN1; SMN2
SCHEMBL17631712 0.76 OGA (0.52) SMN1; SMN2OGAUCHL1
SCHEMBL17632085 0.74 CDK9 (0.36) —
SCHEMBL17631612 0.74 — —
SCHEMBL17631555 0.74 USP30 (0.33) UCHL1
SCHEMBL17632036 0.73 USP30 (0.50) UCHL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP claimed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO claimed
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP disclosed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO disclosed
Send feedback